121 related articles for article (PubMed ID: 2515494)
1. Zinc deficiency and hyperprolactinaemia are not reversible causes of sexual dysfunction in uraemia.
Rodger RS; Sheldon WL; Watson MJ; Dewar JH; Wilkinson R; Ward MK; Kerr DN
Nephrol Dial Transplant; 1989; 4(10):888-92. PubMed ID: 2515494
[TBL] [Abstract][Full Text] [Related]
2. Absence of a therapeutic effect of zinc in the sexual dysfunction of haemodialysed patients.
Brook AC; Johnston DG; Ward MK; Watson MJ; Cook DB; Kerr DN
Lancet; 1980 Sep; 2(8195 pt 1):618-20. PubMed ID: 6107409
[TBL] [Abstract][Full Text] [Related]
3. Reversal of uraemic impotence by zinc.
Antoniou LD; Shalhoub RJ; Sudhakar T; Smith JC
Lancet; 1977 Oct; 2(8044):895-8. PubMed ID: 72240
[TBL] [Abstract][Full Text] [Related]
4. Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence.
De Rosa M; Zarrilli S; Vitale G; Di Somma C; Orio F; Tauchmanova' L; Lombardi G; Colao A
J Clin Endocrinol Metab; 2004 Feb; 89(2):621-5. PubMed ID: 14764772
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral zinc therapy on gonadal function in hemodialysis patients. A double-blind study.
Mahajan SK; Abbasi AA; Prasad AS; Rabbani P; Briggs WA; McDonald FD
Ann Intern Med; 1982 Sep; 97(3):357-61. PubMed ID: 7051913
[TBL] [Abstract][Full Text] [Related]
6. Hormonal profile and serum zinc levels in uraemic men with gonadal dysfunction undergoing haemodialysis.
Joven J; Villabona C; Rubiés-Prat J; Espinel E; Galard R
Clin Chim Acta; 1985 Jun; 148(3):239-45. PubMed ID: 3930099
[TBL] [Abstract][Full Text] [Related]
7. Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled trial.
McCullough AR; Levine LA; Padma-Nathan H
J Sex Med; 2008 Feb; 5(2):476-84. PubMed ID: 18086170
[TBL] [Abstract][Full Text] [Related]
8. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
[TBL] [Abstract][Full Text] [Related]
9. Trial of pentoxifylline for diabetic impotence.
Georgitis WJ; Merenich JA
Diabetes Care; 1995 Mar; 18(3):345-52. PubMed ID: 7555478
[TBL] [Abstract][Full Text] [Related]
10. Zinc deficiency: a reversible complication of uremia.
Mahajan SK; Prasad AS; Rabbani P; Briggs WA; McDonald FD
Am J Clin Nutr; 1982 Dec; 36(6):1177-83. PubMed ID: 6890761
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and pathogenesis of impotence in one hundred uremic men.
Rodger RS; Fletcher K; Dewar JH; Genner D; McHugh M; Wilkinson R; Ward MK; Kerr DN
Uremia Invest; 1984-1985; 8(2):89-96. PubMed ID: 6443249
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine improves reduced libido and potency in men receiving maintenance hemodialysis.
Muir JW; Besser GM; Edwards CR; Rees LH; Cattell WR; Ackrill P; Baker LR
Clin Nephrol; 1983 Dec; 20(6):308-14. PubMed ID: 6357576
[TBL] [Abstract][Full Text] [Related]
13. Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose.
Stark S; Sachse R; Liedl T; Hensen J; Rohde G; Wensing G; Horstmann R; Schrott KM
Eur Urol; 2001 Aug; 40(2):181-8; discussion 189-90. PubMed ID: 11528196
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil improves nocturnal penile erections in organic impotence.
Terradas C; Levalle O; Nagelberg A; Mormandi E
Int J Impot Res; 2001 Apr; 13(2):125-9. PubMed ID: 11426352
[TBL] [Abstract][Full Text] [Related]
15. Hyperprolactinemia and sexual function in men.
Buvat J; Lemaire A; Buvat-Herbaut M; Fourlinnie JC; Racadot A; Fossati P
Horm Res; 1985; 22(3):196-203. PubMed ID: 4054839
[TBL] [Abstract][Full Text] [Related]
16. The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial.
Pohanka M; Kanovský P; Bares M; Pulkrábek J; Rektor I
Parkinsonism Relat Disord; 2005 Dec; 11(8):509-12. PubMed ID: 15994112
[TBL] [Abstract][Full Text] [Related]
17. Penile erections and hypersexuality induced by pergolide treatment in advanced, fluctuating Parkinson's disease.
Kanovský P; Bares M; Pohanka M; Rektor I
J Neurol; 2002 Jan; 249(1):112-4. PubMed ID: 11954860
[No Abstract] [Full Text] [Related]
18. Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy.
Lawrence IG; Price DE; Howlett TA; Harris KP; Feehally J; Walls J
Am J Kidney Dis; 1998 Feb; 31(2):313-9. PubMed ID: 9469503
[TBL] [Abstract][Full Text] [Related]
19. Endocrine assessment of impotence--pitfalls of measuring serum testosterone without sex-hormone-binding globulin.
Hardy KJ; Seckl JR
Postgrad Med J; 1994 Nov; 70(829):836-7. PubMed ID: 7824423
[TBL] [Abstract][Full Text] [Related]
20. The effect of topically applied vasoactive agents and testosterone versus testosterone in the treatment of erectile dysfunction in aged men with low sexual interest.
Gomaa A; Eissa M; El-Gebaley A
Int J Impot Res; 2001 Apr; 13(2):93-9. PubMed ID: 11426345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
